“[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-Per-Responder Analysis]”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 26, no. 1, May 2025, https://doi.org/10.7175/fe.v26i1.1571.